Jeffrey Lightcap - Corindus Vascular Chairman of the Board
Chairman
Mr. Jeffrey C. Lightcap is appointed as Independent Chairman of the Board of the Company, effective August 12, 2014. From March 2008 to August 12, 2014, Mr. Lightcap was elected as a director on August 12, 2014 and was originally appointed by HealthCor as a director of Corindus, Inc. From March 2008 to August 12, 2014, Mr. Lightcap served as a director of Corindus, Inc. and he served as Chairman from April 12, 2012 to August 12, 2014. Since October 2006, Mr. Lightcap has served as a Senior Managing Director at HealthCor Partners Management, LP, a leading growth equity investor in early and near commercial stage healthcare companies in the diagnostic, therapeutic, medtech and HCIT sectors. From 1997 to mid2006, Mr. Lightcap was a Senior Managing Director at JLL Partners, a leading middlemarket private equity firm. Prior to JLL Partners, Mr. Lightcap was a Managing Director at Merrill Lynch Co., Inc. in charge of leverage buyout coverage for Merrill Lynchs mergers and acquisitions group. Prior to joining Merrill Lynch, Mr. Lightcap was a Senior Vice President in the mergers and acquisitions group at Kidder, Peabody Co. and briefly at Salomon Brothers. Mr. Lightcap currently serves as a director of the following companies CareView Communications, Inc., a healthcare technology company IASIS Healthcare Corporationrationration, a privatelyheld company that owns and operates communityfocused hospitals in high growth urban and suburban markets Practice Partners in HealthCare, a privatelyheld company specializing in management and operation of ambulatory surgical centers Paradigm Spine, LLC, a leader in the field of nonfusion, spinal implant technology and HeartFlow, Inc., a company focused on the noninvasive diagnosis of coronary artery disease since 2014.
| Age | 56 |
| Tenure | 10 years |
| Professional Marks | MBA |
| Phone | 508 653-3335 |
| Web | www.corindus.com |
Corindus Vascular Management Efficiency
The company has return on total asset (ROA) of (0.0117) % which means that it has lost $0.0117 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0278) %, meaning that it created substantial loss on money invested by shareholders. Corindus Vascular's management efficiency ratios could be used to measure how well Corindus Vascular manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 15.43 M in liabilities with Debt to Equity (D/E) ratio of 86.5, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Corindus Vascular has a current ratio of 2.95, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Corindus Vascular until it has trouble settling it off, either with new capital or with free cash flow. So, Corindus Vascular's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Corindus Vascular sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Corindus to invest in growth at high rates of return. When we think about Corindus Vascular's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Found 6 records | CHAIRMAN Age | ||
| William Ronald | Fevertree Drinks Plc | 62 | |
| Bill Ronald | Fevertree Drinks Plc | 59 | |
| Lawrence Probst | Electronic Arts | 68 | |
| Jens Bahr | Evolution Gaming Group | 52 | |
| Charles Rolls | Fevertree Drinks Plc | 60 | |
| Nick Caporella | National Beverage Corp | 88 | |
Management Performance
| Return On Equity | -0.0278 | |||
| Return On Asset | -0.0117 |
Corindus Vascular Leadership Team
Elected by the shareholders, the Corindus Vascular's board of directors comprises two types of representatives: Corindus Vascular inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Corindus. The board's role is to monitor Corindus Vascular's management team and ensure that shareholders' interests are well served. Corindus Vascular's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Corindus Vascular's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Scott Madden, IR Contact Officer | ||
| Hillel Bachrach, Director | ||
| David White, Director | ||
| Jeffrey Gold, Director | ||
| Gerard Winkels, Director | ||
| Campbell Rogers, Director | ||
| John Bakewell, Director | ||
| David Handler, CEO and President and Director | ||
| Jeffrey Lightcap, Chairman of the Board | ||
| Douglas Teany, COO | ||
| Michael Mashaal, Director | ||
| James Tobin, Director | ||
| Louis Cannon, Director | ||
| Mark Toland, CEO, Director | ||
| David Long, CFO, Sr. VP, Treasurer and Secretary | ||
| Aquilla Turk, Chief Medical Officer |
Corindus Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Corindus Vascular a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0278 | |||
| Return On Asset | -0.0117 | |||
| Profit Margin | (33.32) % | |||
| Operating Margin | (224.79) % | |||
| Current Valuation | 892.52 M | |||
| Shares Outstanding | 208.53 M | |||
| Shares Owned By Insiders | 23.78 % | |||
| Shares Owned By Institutions | 45.96 % | |||
| Number Of Shares Shorted | 8.7 M | |||
| Price To Earning | (6.51) X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Corindus Vascular in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Corindus Vascular's short interest history, or implied volatility extrapolated from Corindus Vascular options trading.
Pair Trading with Corindus Vascular
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Corindus Vascular position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Corindus Vascular will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Microsoft could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Microsoft when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Microsoft - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Microsoft to buy it.
The correlation of Microsoft is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Microsoft moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Microsoft moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Microsoft can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Consideration for investing in Corindus Stock
If you are still planning to invest in Corindus Vascular check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Corindus Vascular's history and understand the potential risks before investing.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |